Bogle Investment Management’s Esperion Therapeutics ESPR Stock Holding History

Bogle Investment Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-74,961	Closed	-$1.04M	–	352
2016 Q3	$1.04M	Buy	+74,961	New	+$850K	0.07%	256
2015 Q2	–	Sell	-74,291	Closed	-$6.88M	–	377
2015 Q1	$6.88M	Sell	74,291 -47,035	-39%	-$3.04M	0.47%	79
2014 Q4	$4.91M	Buy	+121,326	New	+$3.71M	0.33%	107

Other funds holding ESPR

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return